What Boone Capital Management LLC reported holding on Form 13F for the quarter ended Jun 30, 2026.
CIK 1882053 · Filed Aug 14, 2026
Values are as the managers reported them, in dollars.Open the Form 13F on SEC EDGAR
| 415.6K |
| −1.3% |
| $48.7M |
| 11.4% |
CICigna Group | 159.3K | +15.8% | $43.9M | 10.3% |
IONSIonis Pharmaceuticals Inc | 520K | +3.9% | $41.2M | 9.6% |
UNHUnitedHealth Group Inc | 88.7K | +11.9% | $36.9M | 8.6% |
BMRNBioMarin Pharmaceutical Inc | 583.2K | +6.5% | $33.4M | 7.8% |
GRDNGuardian Pharmacy Services, Inc. | 711.9K | +12.8% | $29.8M | 7% |
VSTSVestis Corp | 1.9M | New | $27.6M | 6.5% |
BBIOBridgeBio Pharma, Inc. | 339.7K | +48.5% | $25.3M | 5.9% |
PNTGPennant Group, Inc. | 515.8K | New | $19.1M | 4.5% |
GLUEMonte Rosa Therapeutics, Inc. | 615.3K | New | $14.9M | 3.5% |
KODKodiak Sciences Inc. | 378K | +34.4% | $14.7M | 3.4% |
TNGXTango Therapeutics, Inc. | 455.6K | New | $14.2M | 3.3% |
KYMRKymera Therapeutics, Inc. | 113.2K | New | $13M | 3% |
CGEMCullinan Therapeutics, Inc. | 704.4K | New | $12.8M | 3% |
ANLAdlai Nortye Group Ltd. | 258.4K | New | $3M | 0.7% |
